Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2001, p. 2179-2180, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2179-2180.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
LETTERS TO THE EDITOR
Inhibitor-Resistant TEM-33
-Lactamase in a Shigella
sonnei Isolate
 |
LETTER |
It has been shown that Shigella species produce a
low-level chromosomally mediated
-lactamase which does not
appreciably affect the level of resistance to
-lactams (2,
10). High rates of resistance to ampicillin among
Shigella isolates are due to the production of
-lactamases similar to TEM-1 or OXA-1. The OXA-type
-lactamase is
more prevalent than TEM-1 in ampicillin-resistant Shigella
flexneri (2, 6, 7, 8). In Shigella sonnei the most commonly produced
-lactamase is the TEM-1 enzyme (2, 6, 7).
We describe here an S. sonnei isolate which was identified
by the API ID 32E system (Bio-Merieux) and by antiserum agglutination and which was obtained in 1998 from stool samples of an 8-year-old child hospitalized at Orléans Hospital (Orléans France) for diarrheal disease that appeared after a 2-month stay in
Turkey. The strain was resistant to amoxicillin and ticarcillin,
either as single drugs or in combination with
clavulanate and piperacillin. It was also resistant to
trimethoprim-sulfamethoxazole and tetracyclines and susceptible to all
cephalosporins, to nalidixic acid, and to fluoroquinolones.
The purpose of the present study was to find the molecular basis of the
resistance to amoxicillin-clavulanate in the S. sonnei isolate (UCK strain). A TEM-1-hyperproducing S. sonnei
strain (CFS01) and an OXA-1-producing S. flexneri strain
(CFS02) were studied as comparators for MIC determinations.
The MICs of amoxicillin, amoxicillin-clavulanate, ticarcillin,
ticarcillin-clavulanate (clavulanic acid at a fixed concentration of 2 µg/ml), and cephalothin were determined by dilution in Mueller-Hinton agar (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France) with an
inoculum of 104 CFU per spot.
The resistance pattern of S. sonnei UCK was characterized by
high MICs of amoxicillin and ticarcillin alone (>2,048 µg/ml) and
combined with clavulanate (2,048 µg/ml), while MICs for the OXA-1-producing S. flexneri CFS02 were much lower
(amoxicillin, 256 µg/ml; amoxicillin-clavulanate, 64 µg/ml;
ticarcillin, 256 µg/ml; ticarcillin-clavulanate, 32 µg/ml). Against
S. sonnei CFS01 (TEM-1 hyperproducing), clavulanate
partially restored the activities of amoxicillin and ticarcillin (MICs,
64 µg/ml for both combinations).
No transconjugant was obtained by mating of S. sonnei
UCK with Escherichia coli HB101 as recipient strain with
ticarcillin (32 µg/ml) as selective agent. Plasmid DNA content was
determined by comparison with plasmids Rsa (39 kb), TP114 (61 kb),
pCFF04 (85 kb), and pCFF14 (180 kb). Strain UCK contained one large
plasmid of ca. 90 kb which hybridized with the TEM probe (data not
shown). Isoelectric focusing performed with polyacrylamide gels
containing ampholines with a pH range of 3.5 to 10.0 showed that
the
-lactamase produced by S. sonnei UCK
focused at a pI of 5.4.
The nucleotide sequence analysis obtained by direct sequencing of
the PCR product revealed that the sequence of the bla gene differed from that of blaTEM-1b at two
positions: a G-162
T transversion (at position 1 of the
10
consensus sequence) in the promoter region and the change A-407
C,
leading to the amino acid substitution Met-69
Leu in the coding
region. The latter change has already been observed in the
inhibitor-resistant TEM
-lactamase IRT-5/TEM-33 (4).
Table 1 shows the sequences of the
structural genes and of the promoter regions specifying this IRT
enzyme. Three different blaTEM-33 genes which
had the mutation A-407
C in common were reported by Goussard and
Courvalin (3): blaTEM-33a,
derived from blaTEM-1b with the change
T-226
C, which is under the control of the weak P3 promoter
(9); blaTEM-33b, derived from
blaTEM-1b, which is under the control of the
strong promoters Pa an Pb; and blaTEM-33c,
derived from blaTEM-2 with the change A-317
C
(Lys-39
Gln), with the promoter region corresponding to the strong P4
promoter with the T-32
C amd G-162
T mutations. The structural gene
of IRT-5/TEM-33 produced by S. sonnei UCK is identical to
blaTEM-33b. The promoter region had the change
G-162
T (P4), which has been shown to be responsible for the
hyperproduction of TEM-1 and which is commonly found upstream from the
genes for inhibitor-resistant
-lactamases (3).
This fourth gene coding for TEM-33 was designated blaTEM-33b-like.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Substitutions in blaTEM genes and
derived genes encoding the inhibitor-resistant -lactamase
TEM-33/IRT-5
|
|
Moderate resistance to amoxicillin-clavulanate (MIC90 = 16 µg/ml) has been frequently reported in S. flexneri
isolates, which often produce a relatively inhibitor-resistant OXA-type
enzyme (2, 8).
The high-level resistance to amoxicillin-clavulanate (2,048 µg/ml) associated with susceptibility to cephalothin (8 µg/ml) observed in S. sonnei (UCK strain) suggested the presence of
a hitherto unreported TEM-33 variant in the species. The sequence diversity observed for the IRT-3/TEM-33 genes lends weight to the idea
that there is a great variety of TEM genes in nature, as previously
suggested by Goussard and Courvalin (3) and as recently
reported by Leflon-Guibout et al. (5). In this study, the
patient had received no antibiotics before the resistant strain was isolated.
 |
ACKNOWLEDGMENTS |
We thank Rolande Perroux, Marlène Jan, and Dominique Rubio
for technical assistance.
This work was supported in part by a grant from Ministère de
l'Education Nationale, de la Recherche et de la Technologie.
 |
FOOTNOTES |
*
*Phone: 33 4 73 60 80 18
Fax: 33 4 73 27 74 94
E-mail: danielle.sirot{at}u-clermont1.fr
 |
REFERENCES |
| 1.
|
Ambler, R. P.,
A. F. W. Coulson,
J. M. Frère,
J. M. Ghuysen,
B. Joris,
M. Forsman,
R. C. Lévesque,
G. Tiraby, and S. G. Waley.
1991.
A standard numbering scheme for the class A -lactamases.
Biochem. J.
276:269-272.
|
| 2.
|
Cavallo, J. D.,
R. Bercion,
J. M. Baudet,
T. Samson,
M. France, and M. Meyran.
1993.
Antibiotic sensitivity of 140 strains of Shigella isolated in Djibouti.
Bull. Soc. Pathol. Exot.
86:35-40[Medline].
|
| 3.
|
Goussard, S., and P. Courvalin.
1999.
Updated sequence information for TEM -lactamase genes.
Antimicrob. Agents Chemother.
43:367-370[Abstract/Free Full Text].
|
| 4.
|
Henquell, C.,
C. Chanal,
D. Sirot,
R. Labia, and J. Sirot.
1995.
Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM -lactamases from clinical isolates of Escherichia coli.
Antimicrob. Agents Chemother.
39:427-430[Abstract/Free Full Text].
|
| 5.
|
Leflon-Guibout, V.,
V. Speldooren,
B. Heym, and M.-H. Nicolas-Chanoine.
2000.
Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of blaTEM genes.
Antimicrob. Agents Chemother.
44:2709-2714[Abstract/Free Full Text].
|
| 6.
|
Navia, M. M.,
L. Capitano,
J. Ruiz,
M. Vargas,
H. Urassa,
D. Schellemberg,
J. Gascon, and J. Villa.
1999.
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania.
J. Clin. Microbiol.
37:3113-3117[Abstract/Free Full Text].
|
| 7.
|
Schumacher, H.,
M. Nir,
B. Mansa, and A. Grassy.
1992.
-Lactamases in Shigella.
APMIS
100:954-956[Medline].
|
| 8.
|
Siu, L. K.,
J. Y. C. Lo,
K. Y. Yuen,
P. Y. Chau,
M. H. Ng, and P. L. Ho.
2000.
-Lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like -lactamase, OXA-30.
Antimicrob. Agents Chemother.
44:2034-2038[Abstract/Free Full Text].
|
| 9.
|
Speldooren, V.,
B. Heym,
R. Labia, and H.-H. Nicolas-Chanoine.
1998.
Discriminatory detection of inhibitor-resistant -lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.
Antimicrob. Agents Chemother.
42:879-884[Abstract/Free Full Text].
|
| 10.
|
Sutcliffe, G.
1978.
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.
Proc. Natl. Acad. Sci. USA
75:3727-3741[Abstract/Free Full Text].
|
| | | | |
D. Sirot*
C. Chanal
R. Bonnet
C. De Champs
J. Sirot
Faculté de Médecine Service de Bactériologie 28 Place Henri-Dunant 63001 Clermont-Ferrand, France
|
| | | | |
L. Bret
Laboratoire de Microbiologie Centre Hospitalier Régional d'Orléans 45032 Orléans, France
|
Antimicrobial Agents and Chemotherapy, July 2001, p. 2179-2180, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2179-2180.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Miro, E., Navarro, F., Mirelis, B., Sabate, M., Rivera, A., Coll, P., Prats, G.
(2002). Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant {beta}-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period. Antimicrob. Agents Chemother.
46: 3991-3994
[Abstract]
[Full Text]